Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Sep 2025 is 142.65% vs 5.08% in Jun 2025
Consolidate Net Profit
QoQ Growth in quarter ended Sep 2025 is 2,343.75% vs 111.29% in Jun 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Sep 2025 is 235.83% vs 168.50% in Jun 2025
Interest
QoQ Growth in quarter ended Sep 2025 is -25.00% vs 33.33% in Jun 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025
Compare Quarterly Results Of Ligand Pharmaceuticals, Inc. With
Quarterly - Net Sales
QoQ Growth in quarter ended Sep 2025 is 142.65% vs 5.08% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 122.97% vs 57.45% in Sep 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Sep 2025 is 2,343.75% vs 111.29% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 1,729.17% vs 30.10% in Sep 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Sep 2025 is 235.83% vs 168.50% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 206.34% vs 109.18% in Sep 2024
Quarterly - Interest
QoQ Growth in quarter ended Sep 2025 is -25.00% vs 33.33% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 28.57% vs 0.00% in Sep 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025
YoY Growth in quarter ended Sep 2025 has improved from Sep 2024






